Hi everyone, have been reading for a while here but now I also want to contribute a bit when possible. I've started an own company earlier this year after having worked in two Big Pharma for the last >5 years. So if you want information around that feel free to ask, I'll be happy to help further if possible!
-
-
Hey
good to know. What are doing in your company in detail? -
Thanks for your answer :-)
Longterm vision is to develop a software package bringing Pharmacogenomics applications into Healthcare, shortterm it is about providing Bioinformatics services at the "Interface" of human genetics and drug information (see e.g. http://de.slideshare.net/jscheiber/f...variance-aug12)Comment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Yesterday, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment